Plain-English translation of NCT06629649 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether community health clinics can use artificial intelligence-powered eye imaging to screen patients for glaucoma and other eye diseases. Glaucoma is a serious condition that can cause blindness if not caught early, yet many people in underserved communities don't have access to regular eye care. The study will compare clinics that offer this new AI-based screening against clinics that only offer standard care.
Most community health clinics serving low-income and minority populations don't have eye doctors or eye care services, which means serious eye diseases like glaucoma often go undetected until significant vision damage has already occurred. This trial exists to see if AI screening technology can help catch these diseases early and get people the care they need.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive eye screening using AI-powered imaging technology at your community health clinic. Some clinics participating in the study will offer this new screening service, while others will continue with standard care (where your doctor simply asks about eye problems). If the screening detects any eye disease or vision problems, you will be referred to an eye specialist for follow-up care.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States